Statistics in Medicine

Papers
(The TQCC of Statistics in Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
146
Skewness‐Corrected Confidence Intervals for Predictive Values in Enrichment Studies124
76
Tracking the transmission dynamics of COVID‐19 with a time‐varying coefficient state‐space model68
Transportability of model‐based estimands in evidence synthesis51
Accounting for Misclassification of Binary Outcomes in External Control Arm Studies for Unanchored Indirect Comparisons: Simulations and Applied Example48
Modeling the multi‐state natural history of rare diseases with heterogeneous individual patient data: A simulation study48
Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule48
BEATS: Bayesian hybrid design with flexible sample size adaptation for time‐to‐event endpoints44
The Whys, Whens, and Hows of Futility Monitoring42
Multi‐Study Factor Regression Model: An Application in Nutritional Epidemiology40
Issue Information38
Issue Information34
Issue Information33
Bayesian Borrowing With Multiple Heterogeneous Historical Studies Using Order Restricted Normalized Power Prior31
Correction to “A Comparison of Methods to Adjust Survival Curves for Confounders”30
Dynamic Single‐Index Scalar‐On‐Function Model29
Optimal confidence intervals for the relative risk and odds ratio28
The polytomous discrimination index for prediction involving multistate processes under intermittent observation28
Handling parametric assumptions in principal causal effect estimation using Gaussian mixtures27
Synthesizing studies for comparing different treatment sequences in clinical trials26
Classification of disease recurrence using transition likelihoods with expectation‐maximization algorithm26
Network and covariate adjusted response‐adaptive design for binary response24
Leveraging External Aggregated Information for the Marginal Accelerated Failure Time Model23
On the parameter estimation of Box‐Cox transformation cure model21
21
Robustness of κ‐type coefficients for clinical agreement21
Real time monitoring and prediction of time to endpoint maturation in clinical trials21
Bayesian additive regression trees for multivariate skewed responses20
A Proposal for Homoskedastic Modeling With Conditional Auto‐Regressive Distributions20
Balancing versus modelling in weighted analysis of non‐randomised studies with survival outcomes: A simulation study20
19
Dose finding studies for therapies with late‐onset toxicities: A comparison study of designs19
19
Cumulative Logit Ordinal Regression With Proportional Odds Under Nonignorable Missing Responses—Application to Phase III Trial18
Semiparametric multivariate joint model for skewed‐longitudinal and survival data: A Bayesian approach18
Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances18
Flexible Empirical Bayesian Approaches to Pharmacovigilance for Simultaneous Signal Detection and Signal Strength Estimation in Spontaneous Reporting Systems Data18
Estimands for factorial trials18
Confidence Intervals for AUC and pAUC by Empirical Likelihood18
Evaluating joint confidence region of hypervolume under ROC manifold and generalized Youden index18
Data fusion for predicting long‐term program impacts18
Bayesian mixture modelling with ranked set samples17
Handling Missing Outcome Data in Cluster Randomized Trials With Both Individual‐ and Cluster‐Level Dropout16
Regression Trees With Fused Leaves16
Generalized additive models to analyze nonlinear trends in biomedical longitudinal data using R: Beyond repeated measures ANOVA and linear mixed models16
A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine15
Relative sparsity for medical decision problems15
Adjusted Nelson–Aalen Estimators by Inverse Treatment Probability Weighting With an Estimated Propensity Score15
A Hierarchical Bayesian Model for Estimating Age‐Specific COVID‐19 Infection Fatality Rates in Developing Countries15
Non‐Parametric Estimation for Semi‐Competing Risks Data With Event Misascertainment15
A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart14
Estimating contact network properties by integrating multiple data sources associated with infectious diseases14
Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low‐income adults14
Multiple multi‐sample testing under arbitrary covariance dependency14
Kernel Cox partially linear regression: Building predictive models for cancer patients' survival14
A combined multilevel factor analysis and covariance regression model with mixed effects in the mean and variance structure14
Adjusted closed‐form confidence interval formulas for network meta‐analysis with a small number of studies14
An inverse probability weighted regression method that accounts for right‐censoring for causal inference with multiple treatments and a binary outcome14
Issue Information14
Sensitivity analysis of G‐estimators to invalid instrumental variables14
Multilevel joint model of longitudinal continuous and binary outcomes for hierarchically structured data14
Multilevel Longitudinal Functional Principal Component Model13
Information‐incorporated sparse hierarchical cancer heterogeneity analysis13
Nonparametric empirical Bayes biomarker imputation and estimation13
A shared‐parameter location‐scale mixed model to link the responsivity in self‐initiated event reports and the event‐contingent Ecological Momentary Assessments13
Distribution–free hyperrectangular tolerance regions for setting multivariate reference regions in laboratory medicine13
A Bayesian method to detect drug‐drug interaction using external information for spontaneous reporting system13
Model‐assisted analyses of longitudinal, ordinal outcomes with absorbing states13
Modeling variation in mixture effects over space with a Bayesian spatially varying mixture model13
Weighted McNemar's test for the comparison of two screening tests in the presence of verification bias13
Covariate adjustment in randomized clinical trials with missing covariate and outcome data12
Quantile partially linear additive model for data with dropouts and an application to modeling cognitive decline12
A systematic review and evaluation of statistical methods for group variable selection12
Natural Effects in the Presence of an Intermediate Confounder: Evaluation of Pragmatic Estimation Strategies With an Emphasis on the Relationship Between Natural and Interventional Effects12
12
What's the Weight? Estimating Controlled Outcome Differences in Complex Surveys for Health Disparities Research12
Robust Estimation of Additive Shared‐Frailty Models for Recurrent Event Data With Dependent Censoring12
Outlier Detection in Mendelian Randomization12
Finding the best subgroup with differential treatment effect with multiple outcomes12
Instrumental variable model average with applications in Mendelian randomization12
Variability in Causal Effects and Noncompliance in a Multisite Trial: A Bivariate Hierarchical Generalized Random Coefficients Model for a Binary Outcome11
Modeling intra‐individual inter‐trial EEG response variability in autism11
IDNetwork: A deep illness‐death network based on multi‐state event history process for disease prognostication11
Genetic Prediction Modeling in Large Cohort Studies via Boosting Targeted Loss Functions11
Asymptotic Confidence Interval, Sample Size Formulas and Comparison Test for the Agreement Intra‐Class Correlation Coefficient in Inter‐Rater Reliability Studies11
11
11
Standardization and other approaches to meta‐analyze differences in means11
11
11
11
A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time‐To‐Event Outcomes Using Average Hazard With Survival Weight11
Random Survival Forest With Multiple Imputation Analysis for Case‐Cohort and Generalized Case‐Cohort Studies11
Issue Information10
Handling missing within‐study correlations in the evaluation of surrogate endpoints10
Obituary: Anthony Leonard Johnson (1943‐2022)10
Optimal weighted Bonferroni tests and their graphical extensions10
Joint regression modelling of intensity and timing of accelerometer counts10
Local false discovery rate estimation with competition‐based procedures for variable selection10
Issue Information10
Issue Information10
Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial10
Q‐Learning in Dynamic Treatment Regimes With Misclassified Binary Outcome9
Improve the Precision of Area Under the Curve Estimation for Recurrent Events Through Covariate Adjustment9
Penalized smoothing splines resolve the curvature identifiability problem in age‐period‐cohort models with unequal intervals9
A non‐parametric Bayesian approach for adjusting partial compliance in sequential decision making9
Estimating mixture effects and cumulative spatial risk over time simultaneously using a Bayesian index low‐rank kriging multiple membership model9
Distribution‐free model selection for longitudinal zero‐inflated count data with missing responses and covariates9
Propensity score analysis with local balance9
An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation9
Transfer Learning for Error‐Contaminated Poisson Regression Models9
Flexible template matching for observational study design9
Robust inference for causal mediation analysis of recurrent event data9
Association analysis of self‐reported outcomes with a validated subset9
A Brief Introduction on Latent Variable Based Ordinal Regression Models With an Application to Survey Data9
Structured time‐dependent inverse regression (STIR)9
Group sequential designs for clinical trials when the maximum sample size is uncertain9
Subgroup Testing in the Change‐Plane Cox Model9
Complex survival trial design by the product integration method9
Analysis of composite endpoints with component‐wise censoring in the presence of differential visit schedules9
Combining information to estimate adherence in studies of pre‐exposure prophylaxis for HIV prevention: Application to HPTN 0679
Correction to “Using principal stratification in analysis of clinical trials”9
9
Frequentist Grouped Weighted Quantile Sum Regression for Correlated Chemical Mixtures8
Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation8
Designing individually randomized group treatment trials with repeated outcome measurements using generalized estimating equations8
Causal inference methods for vaccine sieve analysis with effect modification8
8
Identification and robust estimation of swapped direct and indirect effects: Mediation analysis with unmeasured mediator‐outcome confounding and intermediate confounding8
Saddlepoint approximations to score test statistics in logistic regression for analyzing genome‐wide association studies8
Flexible propensity score estimation strategies for clustered data in observational studies8
On “Confirmatory” Methodological Research in Statistics and Related Fields8
Accounting for unequal cluster sizes in designing cluster randomized trials to detect treatment effect heterogeneity8
BHAFT: Bayesian heredity‐constrained accelerated failure time models for detecting gene‐environment interactions in survival analysis8
8
Multi‐threshold proportional hazards model and subgroup identification8
Statistical inference for time‐to‐event data in non‐randomized cohorts with selective attrition8
Ensemble of Sequential Learning Models With Distributed Data Centers and Its Applications8
Peter Armitage speaking on the occasion of the 50th Anniversary of the M.Sc. in Medical Statistics, LSHTM (for the Symposium on April 11‐12, 2019)8
Bland–Altman Plot for Censored Variables8
A Bayesian Two‐Step Multiple Imputation Approach Based on Mixed Models for Missing EMA Data8
8
8
8
A sequential, multiple assignment, randomized trial design with a tailoring function8
Split and combine simulation extrapolation algorithm to correct geocoding coarsening of built environment exposures8
Robust structured heterogeneity analysis approach for high‐dimensional data8
The impact of correlated exposures and missing data on multiple informant models used to identify critical exposure windows8
Confidence intervals for odds ratio from multistage randomized phase II trials7
A Bayesian Multivariate Model With Temporal Dependence on Random Partition of Areal Data for Mosquito‐Borne Diseases7
Sample size determination for prediction models via learning‐type curves7
A Varying‐Coefficient Additive Hazard Model for Recurrent Events Data7
Issue Information7
Minimization in randomized clinical trials7
On GEE for Mean‐Variance‐Correlation Models: Variance Estimation and Model Selection7
MERIT: Controlling Monte‐Carlo error rate in large‐scale Monte‐Carlo hypothesis testing7
Accounting for publication bias using a bivariate trim and fill meta‐analysis procedure7
Deep Mixture of Linear Mixed Models for Complex Longitudinal Data7
Causal Inference for First Non‐Fatal Events With the Competing Risk of Death: A Principal Stratification Approach7
A classification for complex imbalanced data in disease screening and early diagnosis7
Multilevel Regression and Poststratification Using Margins of Poststratifiers: Improving Inference for HIV Health Outcomes During the COVID‐19 Pandemic7
A distribution‐free procedure for testing versatile alternative in medical multisample comparison studies7
Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints7
Issue Information7
The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints7
Issue Information7
Issue Information7
Accommodating Spatial Heterogeneity in Geographically Weighted Regression with Group Penalty7
Profile‐likelihood Bayesian model averaging for two‐sample summary data Mendelian randomization in the presence of horizontal pleiotropy7
Blinded sample size re‐estimation for comparing over‐dispersed count data incorporating follow‐up lengths7
A Practical Framework to Design Immunization Studies Based on the Beta Distribution7
A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards7
A Unified Framework for Modeling Feedback and Endogeneity in Longitudinal Binary Outcomes Using Bayesian Methods7
Testing for the Functional Form of a Continuous Covariate in the Shared‐Parameter Joint Model7
Scaled average bioequivalence methods for highly variable drugs: Leveling‐off soft limits and the EMA's 2010 guideline (some ways to improve its type I error control)7
A Simple Diagnostic for the Positivity Assumption for Continuous Exposures7
Issue Information7
A nonparametric simultaneous confidence band for biomarker effect on the restricted mean survival time7
Depthgram: Visualizing outliers in high‐dimensional functional data with application to fMRI data exploration7
Unlocking Cognitive Analysis Potential in Alzheimer's Disease Clinical Trials: Investigating Hierarchical Linear Models for Analyzing Novel Measurement Burst Design Data7
Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance7
An Alternative Measure for Quantifying the Heterogeneity in Meta‐Analysis7
Federated causal inference in heterogeneous observational data7
A function‐based approach to model the measurement error in wearable devices7
Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies7
Using a mixed‐effect model with a parameter‐space of heterogenous dimension to evaluate whether accountable care organizations are associated with greater uniformity across constituent practices6
A proper statistical inference framework to compare clinical trial and real‐world progression‐free survival data6
Fitting additive risk models using auxiliary information6
A comparison of different methods to adjust survival curves for confounders6
Parameter estimation and forecasting with quantified uncertainty for ordinary differential equation models using QuantDiffForecast: A MATLAB toolbox and tutorial6
Low‐rank latent matrix‐factor prediction modeling for generalized high‐dimensional matrix‐variate regression6
6
Penalized maximum likelihood inference under the mixture cure model in sparse data6
Trial emulation and survival analysis for disease incidence registers: A case study on the causal effect of pre‐emptive kidney transplantation6
A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials6
Distributional imputation for the analysis of censored recurrent events6
Fast estimation of mixed‐effects location‐scale regression models6
Gaussian variational approximate inference for joint models of longitudinal biomarkers and a survival outcome6
Approximate likelihood‐based estimation method of multiple‐type pathogen interactions: An application to longitudinal pneumococcal carriage data6
Radiomics of PET Using Neural Networks for Prediction of Alzheimer's Disease Diagnosis6
Multiple imputation approaches for handling incomplete three‐level data with time‐varying cluster‐memberships6
Assessing heterogeneity in surrogacy using censored data6
A Bayesian semi‐parametric scalar‐on‐function regression with measurement error using instrumental variables6
Score Test for Functional Markov Process With Image Predictor6
Fusing trial data for treatment comparisons: Single vs multi‐span bridging6
Bayesian Modeling of Cancer Outcomes Using Genetic Variables Assisted by Pathological Imaging Data6
Robust analysis of cancer heterogeneity for high‐dimensional data6
Subgroup analysis using Bernoulli‐gated hierarchical mixtures of experts models6
Tony Johnson—memories and a tribute6
6
Multiblock partial least squares and rank aggregation: Applications to detection of bacteriophages associated with antimicrobial resistance in the presence of potential confounding factors6
Exploiting relationship directionality to enhance statistical modeling of peer‐influence across social networks6
6
Fitting a stochastic model of intensive care occupancy to noisy hospitalization time series during the COVID‐19 pandemic6
Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs6
Bayesian predictive model averaging approach to joint longitudinal‐survival modeling: Application to an immuno‐oncology clinical trial6
Allocation in platform trials to maintain comparability across time and eligibility6
A Note on the Sample Size Formula for a Win Ratio Endpoint6
Multivariate functional mixed model with MRI data: An application to Alzheimer's disease6
Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo6
Properties of the full random‐effect modeling approach with missing covariate data6
A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability‐nonexchangeability method6
Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis6
Optimal ensemble construction for multistudy prediction with applications to mortality estimation6
Reinforced Borrowing Framework: Leveraging Auxiliary Data for Individualized Inference6
Mixed‐type multivariate response regression with covariance estimation6
Sensitivity Analysis for Effects of Multiple Exposures in the Presence of Unmeasured Confounding: Non‐Gaussian and Time‐to‐Event Outcomes6
Sample size calculation for randomized selection trials with a time‐to‐event endpoint and a margin of practical equivalence5
Shared decision making of burdensome surveillance tests using personalized schedules and their burden and benefit5
Integrating Complex Selection Rules Into the Latent Overlapping Group Lasso for the Construction of Coherent Prediction Models5
Issue Information5
Issues with the expected information matrix of linear mixed models provided by popular statistical packages under missingness at random dropout5
Individualized empirical null estimation for exact tests of healthcare quality5
Likelihood ratio combination of multiple biomarkers via smoothing spline estimated densities5
False Discovery Estimation in Record Linkage5
A Joint Model for (Un)Bounded Longitudinal Markers, Competing Risks, and Recurrent Events Using Patient Registry Data5
Issue Information5
Issue Information5
New late‐emphasis and combination tests based on infimum and supremum logrank statistics with application in oncology trials5
Bayesian federated inference for estimating statistical models based on non‐shared multicenter data sets5
Issue Information5
Adaptive Biomarker‐Based Design for Early Phase Clinical Trials5
Enhancing long‐term survival prediction with two short‐term events: Landmarking with a flexible varying coefficient model5
Improving the Effectiveness of Sample Size Re‐Estimation: An Operating Characteristic Focused, Hybrid Frequentist‐Bayesian Approach5
Multiple Imputation of Missing Covariates When Using the Fine–Gray Model5
Testing a global null hypothesis using ensemble machine learning methods5
Approximate Bayesian computation for the natural history of breast cancer, with application to data from a Milan cohort study5
Overall assessment for selected markers from high‐throughput data5
Two‐stage targeted maximum likelihood estimation for mixed aggregate and individual participant data analysis with an application to multidrug resistant tuberculosis5
0.07079291343689